Archive for 2016

Trump in 30 seconds: Science and medicine in flux

The latest on what the Trump presidency means for health care, hospitals, drug companies, and medical research. Tuesday, Nov. 15 The big news right now Even if Trump ends up being a friend to pharma, the private sector – and particularly pharmacy benefit managers – are set to put increasing pressure on drug prices. (Bloomberg) […]


Which drug makers do a good job getting poor patients access to their medicines?

The pharmaceutical industry is regularly chastised for failing to do enough to ensure that people in low and middle-income countries have access to its medicines. Yet the real picture is actually more nuanced, according to a newly released report that finds some – but not all – drug makers are making headway. Some companies, for […]


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog